ZA200709813B - (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one - Google Patents

(5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one

Info

Publication number
ZA200709813B
ZA200709813B ZA200709813A ZA200709813A ZA200709813B ZA 200709813 B ZA200709813 B ZA 200709813B ZA 200709813 A ZA200709813 A ZA 200709813A ZA 200709813 A ZA200709813 A ZA 200709813A ZA 200709813 B ZA200709813 B ZA 200709813B
Authority
ZA
South Africa
Prior art keywords
quinoxalinylmethylidene
thiazol
dichlorophenyl
amino
Prior art date
Application number
ZA200709813A
Other languages
English (en)
Inventor
Kevin J Duffy
Duke M Fitch
Beth A Norton
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA200709813B publication Critical patent/ZA200709813B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200709813A 2005-06-08 2007-11-14 (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one ZA200709813B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68867105P 2005-06-08 2005-06-08

Publications (1)

Publication Number Publication Date
ZA200709813B true ZA200709813B (en) 2008-09-25

Family

ID=37532819

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709813A ZA200709813B (en) 2005-06-08 2007-11-14 (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one

Country Status (21)

Country Link
US (1) US7674792B2 (xx)
EP (1) EP1888531A4 (xx)
JP (1) JP2008543770A (xx)
KR (1) KR20080014017A (xx)
CN (1) CN101193863A (xx)
AP (1) AP2007004241A0 (xx)
AR (1) AR054059A1 (xx)
AU (1) AU2006258032A1 (xx)
BR (1) BRPI0611096A2 (xx)
CA (1) CA2611480A1 (xx)
EA (1) EA200702457A1 (xx)
IL (1) IL187423A0 (xx)
MA (1) MA29567B1 (xx)
MX (1) MX2007015572A (xx)
NO (1) NO20080130L (xx)
NZ (1) NZ563421A (xx)
PE (1) PE20070083A1 (xx)
TW (1) TW200716580A (xx)
UY (1) UY29581A1 (xx)
WO (1) WO2006135712A2 (xx)
ZA (1) ZA200709813B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008543769A (ja) * 2005-06-08 2008-12-04 スミスクライン・ビーチャム・コーポレイション （５ｚ）−５−（６−キノキサリニルメチリデン）−２−［（２，４，６−トリクロロフェニル）アミノ］−１，３−チアゾール−４（５ｈ）−オン
US20100286041A1 (en) * 2007-03-22 2010-11-11 Smithkline Beecham Corporation (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
WO2008150837A1 (en) * 2007-06-01 2008-12-11 Smithkline Beecham Corporation Methods of treatment

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545648A (en) 1978-09-29 1980-03-31 Teikoku Hormone Mfg Co Ltd 2-formyldibenzazepin derivative and its preparation
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
JP2539504B2 (ja) * 1987-03-11 1996-10-02 鐘淵化学工業株式会社 ヒドロキシスチレン誘導体
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
JPH0197926A (ja) 1987-10-09 1989-04-17 Idemitsu Kosan Co Ltd 有機非線型光学材料
DD270072A1 (de) 1988-03-14 1989-07-19 Univ Halle Wittenberg Verfahren zur herstellung von 5-aryliden- hoch 2-thiazolin-4-onen
US5306822A (en) 1988-05-25 1994-04-26 Warner-Lambert Company Arylmethylenyl derivatives of oxazolidinone
US5145753A (en) * 1989-09-12 1992-09-08 Mitsubishi Jukogyo Kabushiki Kaisha Solid electrolyte fuel cell
US5053420A (en) 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
JPH052200A (ja) 1990-09-28 1993-01-08 Toshiba Corp 有機非線形光学材料
EP0554834B1 (en) 1992-02-03 1998-06-03 Fuji Photo Film Co., Ltd. Process for dispersing dyestuff and silver halide photographic material containing dyestuff
JP2835246B2 (ja) 1992-06-02 1998-12-14 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DE69331891T2 (de) * 1992-09-11 2002-10-31 Agfa Gevaert Nv Photographisches Element,das einen Filterfarbstoff enthält, für Schnellverarbeitungs-Verwendungen
DE69333314D1 (de) * 1992-09-11 2004-01-08 Agfa Gevaert Nv Photographisches Element,das einen Filterfarbstoff enthält, für Schnellverarbeitungs-Verwendungen
JPH06128234A (ja) 1992-10-19 1994-05-10 Fuji Photo Film Co Ltd 不斉炭素原子を有する化合物およびそれからなる非線形光学材料
US5554767A (en) * 1993-05-21 1996-09-10 Warner-Lambert Company Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
EP0687573A1 (en) * 1994-06-13 1995-12-20 Agfa-Gevaert N.V. Dye donor element for use in a thermal dye transfer method
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体
JPH08109176A (ja) 1994-10-07 1996-04-30 Torii Yakuhin Kk イソローダニンｎ酢酸誘導体
IL117208A0 (en) 1995-02-23 1996-06-18 Nissan Chemical Ind Ltd Indole type thiazolidines
US5618835A (en) * 1996-02-01 1997-04-08 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
JPH09255669A (ja) 1996-03-22 1997-09-30 Hisamitsu Pharmaceut Co Inc 新規なベンジリデン誘導体
US5958957A (en) * 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6632947B2 (en) * 1997-02-18 2003-10-14 Smithkline Beecham Plc Process for the preparation of substituted thiazolidinedione
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
WO1999059586A1 (en) 1998-05-19 1999-11-25 Regents Of The University Of California Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
AU6330999A (en) 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US6221613B1 (en) * 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US6689491B1 (en) * 1999-02-08 2004-02-10 Fuji Photo Film Co., Ltd. Luminescent device material, luminescent device using the same, and amine compound
US6372742B1 (en) * 1999-07-01 2002-04-16 Geron Corporation Substituted indole compounds and methods of their use
JP2001072592A (ja) * 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
US6720345B1 (en) * 1999-11-05 2004-04-13 Smithkline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
US7005288B1 (en) * 1999-11-10 2006-02-28 Novozymes A/S Fungamyl-like alpha-amylase variants
JP2001348520A (ja) * 2000-04-03 2001-12-18 Fuji Photo Film Co Ltd メチン化合物、固体微粒子分散物、インクジェット用記録液、およびインクジェット記録方法
CY2010012I2 (el) 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
EP1299362A4 (en) 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
US6410734B1 (en) * 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
DE10115227A1 (de) * 2001-03-28 2002-12-19 Bayer Ag Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren
US6452014B1 (en) * 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US7087758B2 (en) * 2001-04-06 2006-08-08 Smithkline Beecham Corporation Quinoline inhibitors of hyaki and hyak3 kinases
AR037714A1 (es) * 2001-12-06 2004-12-01 Maxia Pharmaceuticals Inc Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
AU2003284217A1 (en) * 2002-10-16 2004-05-04 Smithkline Beecham Corporation Chemical compounds
DK1567112T3 (da) * 2002-11-22 2009-02-09 Smithkline Beecham Corp Thiazolidin-4-oner til at hæmme hYAK3-proteiner
US7645421B2 (en) * 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
ES2328146T3 (es) * 2003-07-28 2009-11-10 Merck Serono Sa 2-imino-4-(tio)oxo-5-policiclovinilazolinas para su uso como inhibidores de p13 quinasas.
WO2005016227A2 (en) * 2003-08-14 2005-02-24 Insight Biopharmaceuticals Ltd. Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
EP1718297A4 (en) 2004-01-09 2009-09-02 Smithkline Beecham Corp NEW CHEMICAL COMPOUNDS
WO2005076854A2 (en) 2004-02-04 2005-08-25 Smithkline Beecham Corporation Pyrimidinone compounds useful as kinase inhibitors
WO2005082363A1 (en) 2004-02-20 2005-09-09 Board Of Regents, The University Of Texas System Thiazolone compounds for treatment of cancer
JP2007523957A (ja) 2004-02-25 2007-08-23 スミスクライン・ビーチャム・コーポレイション 新規化学化合物
ES2317238T3 (es) * 2004-07-01 2009-04-16 F. Hoffmann-La Roche Ag Quinolina-tiazolinonas con actividad antiproliferante cdk-1.
MXPA06015028A (es) * 2004-07-01 2007-02-08 Hoffmann La Roche Tiazolinas cinolinas no sustituidas.
US7253285B2 (en) * 2004-09-17 2007-08-07 Hoffmann-La Roche Inc. Thiazolinone 4-monosubstituted quinolines
TW200716132A (en) 2005-05-03 2007-05-01 Smithkline Beecham Corp Novel chemical compounds
JP2008545690A (ja) 2005-05-23 2008-12-18 スミスクライン・ビーチャム・コーポレイション 新規化合物
JP2008543769A (ja) 2005-06-08 2008-12-04 スミスクライン・ビーチャム・コーポレイション （５ｚ）−５−（６−キノキサリニルメチリデン）−２−［（２，４，６−トリクロロフェニル）アミノ］−１，３−チアゾール−４（５ｈ）−オン

Also Published As

Publication number Publication date
CN101193863A (zh) 2008-06-04
WO2006135712A3 (en) 2007-06-28
EP1888531A2 (en) 2008-02-20
AU2006258032A1 (en) 2006-12-21
JP2008543770A (ja) 2008-12-04
MA29567B1 (fr) 2008-06-02
NZ563421A (en) 2010-07-30
EA200702457A1 (ru) 2008-04-28
BRPI0611096A2 (pt) 2010-12-21
WO2006135712A2 (en) 2006-12-21
AR054059A1 (es) 2007-05-30
AP2007004241A0 (en) 2007-12-31
MX2007015572A (es) 2008-02-25
UY29581A1 (es) 2006-11-30
US20070179144A1 (en) 2007-08-02
CA2611480A1 (en) 2006-12-21
PE20070083A1 (es) 2007-01-27
KR20080014017A (ko) 2008-02-13
TW200716580A (en) 2007-05-01
US7674792B2 (en) 2010-03-09
NO20080130L (no) 2008-01-08
EP1888531A4 (en) 2009-06-17
IL187423A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
EP1555267A4 (en) 2,3-dihydro-6-NITROIMIDAZOç2,1-b] oxazoles
GB2429668B (en) Locking chuck
EP1831226A4 (en) CHIRAL COMPOUNDS WITH CYCLE 1,2 IMIDAZO 4,5-c FUSIONNE
EP1881773A4 (en) LOCKING CHUCK
EP1831221A4 (en) CHIRAL COMPOUNDS 1,2 IMIDAZO 4,5-C SUBSTITUTED FUSED CORE
GB2428609B (en) Chuck
AP2006003525A0 (en) Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
PT2468732E (pt) 1h-quinazolino-2,4-dionas e sua utilização como ligandos dos receptores ampa
EP1994850A4 (en) HAIR HOLDER, SWITCHING DEVICE FOR HAIR HOLDER AND HAIR HOLDER FOR HAIR TREATMENT
GB0525260D0 (en) Chuck with improved sleeve
AP2007003958A0 (en) Peptide cyclisation
PL1963295T3 (pl) Pochodne 3,6-dihydro-2-okso-6h-[1,3,4]tiadiazyny
IL173324A0 (en) Benzoxazepine compound
GB0305027D0 (en) Bio cell cleaning centrifuge having detachable chamber body
PT1713606E (pt) Elemento de aperto para porta ferramentas
IL187423A0 (en) (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl) amino]-1,3-thiazol-4(5h)-one
GB0328107D0 (en) Chuck
ZA200410232B (en) Aminoacetonitrile derivatives suitable for controlling parasites.
GB2404447B (en) Camera body
EP1888557A4 (en) (5Z) -5- (6-QUINOXALINYLMETHYLIDENE) -2-Ý (2,4,6-trichlorophenyl) amino-1,3-thiazol-4 (5H) -one
ZA200702296B (en) Peptide cyclisation
GB2418383B (en) Chuck for angular offset woodturning
GB0310753D0 (en) The hammock rocker
HU0200200V0 (en) Seat or dumpy, particularly for out-air show
GB0221777D0 (en) T s valve arrangement